Biotech Values

[drbio45]

I am assuming nothing.

Considering that sales are not high and I don't think they will ramp quickly, the market cap seems high.

If sales were ramping quicker I would say competitors might have a problem encroaching their territory. But since the ramp is slow other competitors might give them a problem.

I have no doubt that the technology is useful and meaningful.

I believe I was the first person to mention the technology on this board.

The stock was a lot cheaper then and the sales aren't much higher now